A lateral flow assay (LFA) is a paper-based, single-use diagnostic test that detects a target analyte in a liquid sample by moving the sample along a membrane strip through capillary action. The result appears as one or more visible lines within minutes, without laboratory instruments or specialized training. Lateral flow assays are used in pregnancy tests, infectious disease screening, cardiac marker testing, drug screening, and many other point-of-care diagnostic settings.
This guide explains how lateral flow assays work, what each component of the test strip does, how the main assay formats differ, where the tests are used, what their limitations are, and how they are manufactured in outline. Anyone evaluating or developing rapid diagnostic products will find the fundamentals here.
What is a lateral flow assay?
A lateral flow assay is a type of immunochromatographic assay. It uses antibodies, or in some cases other binding molecules, to recognize a specific analyte such as a viral antigen, a hormone, a protein biomarker, or a small-molecule drug. The reaction takes place on a porous membrane, and the readout is typically a colored or fluorescent line that can be interpreted visually or with a small electronic reader.
The term “lateral flow” refers to the way the liquid sample travels sideways along the strip, driven by capillary forces rather than by pumps or external power. This passive transport is what makes the format compact, inexpensive per test, and suitable for use outside the laboratory.
How lateral flow assays work
The operating principle combines fluid transport with specific molecular recognition. A liquid sample is applied to one end of the strip and wicks through the porous materials in sequence. Along the way it rehydrates dried detection reagents, carries them to the reaction zone, and finally reaches a pad that absorbs the excess liquid.
Capillary action and sample transport
Capillary action is the movement of a liquid through narrow pores without external force. The pores in the sample pad, conjugate pad, and nitrocellulose membrane draw the liquid forward, and the absorbent pad at the end maintains the flow by pulling fluid through the strip. The pore structure of each material determines how fast the sample moves, which in turn affects how long the analyte and reagents have to interact. Flow that is too fast can reduce sensitivity, while flow that is too slow can extend the test time or cause uneven results.
From sample application to result
The sequence of events in a typical test is as follows:
- Sample application. The sample, or the sample mixed with a buffer, is applied to the sample pad. The pad conditions the sample and can filter particulates.
- Conjugate release. The sample reaches the conjugate pad and rehydrates the dried labeled detection reagent, usually an antibody attached to colloidal gold, latex, or a fluorescent particle.
- Complex formation. If the target analyte is present, it binds to the labeled reagent and forms a complex as the mixture continues to move.
- Capture at the test line. On the nitrocellulose membrane, immobilized capture molecules at the test line bind the complex, concentrating the label into a visible line.
- Control line confirmation. Unbound labeled reagent continues to the control line, where a separate capture molecule binds it. A visible control line indicates that the sample flowed correctly and the reagents were active.
- Result interpretation. The user, or a reader device, interprets the line pattern. The control line must appear for the result to be valid.
Lateral flow assay components
A lateral flow test strip is a multilayer assembly in which each material has a defined function. The performance of the finished test depends on how well these materials work together, not only on the quality of each one in isolation.
| Component | Function | Key considerations |
|---|---|---|
| Sample pad | Receives the sample, filters particulates, and conditions it for flow | Material choice affects flow rate, sample compatibility, and non-specific binding |
| Conjugate pad | Stores dried, labeled detection reagent and releases it when wetted | Reagent stability and consistent release are critical for reproducible signal |
| Nitrocellulose membrane | Provides the reaction surface where capture molecules form the test and control lines | Pore size and protein binding capacity influence flow speed, sensitivity, and line quality |
| Test line | Captures the analyte-label complex and produces the result signal | Capture reagent density and placement affect signal strength |
| Control line | Confirms that the sample migrated and the reagents functioned | Must appear for a valid result |
| Absorbent pad | Draws fluid through the strip and holds excess liquid | Capacity influences total sample volume and flow consistency |
| Backing card | Holds the layers in alignment and provides mechanical support | Adhesive and substrate compatibility with the other materials |
The strip is normally housed in a plastic cassette or dipstick holder that protects it, defines the sample application area, and provides a window for reading the result. The interfaces where pads overlap are particularly important, because poor contact can interrupt capillary flow even when every individual material performs well.
Lateral flow assay formats: sandwich and competitive
The two main assay formats differ in how the signal relates to the amount of analyte in the sample. The choice depends mainly on the size and structure of the analyte.
Sandwich format
In the sandwich format, the analyte is bound by two antibodies at the same time: a labeled detection antibody on the conjugate pad and a capture antibody at the test line. The analyte forms a “sandwich” between them. The signal intensity increases with analyte concentration, and the presence of a test line indicates a positive result. This format is typically used for larger analytes with at least two binding sites, such as proteins, viral antigens, and many hormones. Pregnancy tests and many infectious disease antigen tests follow this design.
Competitive format
Competitive formats are typically used for small molecules, such as drugs, toxins, and some hormones, which are too small to bind two antibodies at once. Here the analyte in the sample competes with an immobilized analyte analogue at the test line for a limited amount of labeled antibody. The result is inverted: a strong test line means little or no analyte is present, and a weak or absent test line indicates a positive result.
Some tests use variations on these formats, including multiplexed strips with several test lines for different analytes. Format selection is a core assay design decision, since it affects sensitivity, the dynamic range, and how results must be interpreted.
Applications of lateral flow assays
Lateral flow assays are valued where speed, simplicity, and low infrastructure requirements matter. Common application areas include:
- Point-of-care diagnostics. Tests performed near the patient, in clinics, pharmacies, emergency settings, or at home, where a rapid result can support timely decisions.
- Infectious disease testing. Rapid antigen and antibody tests for pathogens such as influenza, SARS-CoV-2, HIV, malaria, and streptococcal infections.
- Reproductive health. Pregnancy and ovulation tests, among the best-known consumer lateral flow products.
- Cardiac and other biomarkers. Quantitative or semi-quantitative tests for markers such as troponin, usually paired with a reader.
- Toxicology and drug screening. Competitive-format tests for drugs of abuse and certain toxins.
- Non-clinical uses. Food safety, veterinary diagnostics, agriculture, and environmental testing.
For human diagnostics, these products fall within the broader field of in vitro diagnostic devices, which is subject to regulatory requirements that vary by region and intended use.
Limitations of lateral flow assays
Lateral flow assays are useful screening and decision-support tools, but their limitations should be understood when selecting or developing a test.
- Sensitivity. Visual lateral flow tests generally have higher detection limits than laboratory methods such as ELISA or PCR. Low analyte concentrations, such as early in an infection, may produce false negatives.
- Specificity and cross-reactivity. Antibodies may bind to structurally similar molecules, producing false positive signals. Reagent selection and validation against related analytes are essential.
- Matrix effects. Whole blood, urine, saliva, and nasal swab extracts differ in viscosity, pH, salts, and interfering substances, all of which can affect flow and binding. Sample pad design and buffer composition are used to reduce these effects.
- Hook effect. Very high analyte concentrations can saturate both the labeled and capture antibodies separately, weakening the test line signal and potentially producing a false negative.
- Test conditions. Temperature, humidity, sample volume, timing of the read, and storage conditions can all influence performance. Reading a result too early or too late can change the interpretation.
- Result interpretation. Faint lines are subjective when read by eye. Reader devices can improve objectivity and enable semi-quantitative results, but they add cost and complexity.
- Quantification. Standard visual tests are qualitative or semi-quantitative. Accurate quantitative measurement usually requires a calibrated reader and a validated assay.
Positive and negative results from rapid tests often need confirmation by a reference method, depending on the clinical context and the performance characteristics of the specific test.
How lateral flow assays are manufactured: an overview
At a high level, lateral flow test strips are produced by preparing the component materials, applying the capture and detection reagents, assembling the layers on a backing card, cutting the assembled sheet into individual strips, and packaging them, usually in protective pouches with desiccant. Because the membrane, pads, and adhesives must be consistent and compatible, material selection and process control strongly influence the performance and reproducibility of the finished test.
Detailed process steps, material handling, production controls, and scale-up considerations are covered in a dedicated article: lateral flow assay manufacturing: process, materials, and scale.
Supporting diagnostic product development with Screentec
Screentec is a Finnish contract development and manufacturing organization (CDMO) with expertise in printed electronics, diagnostic components, electrochemical sensors, and specialized manufacturing. Organizations developing diagnostic products can discuss relevant manufacturing requirements with Screentec to understand how its capabilities may fit their project.
This content was generated with the help of AI and it may contain mistakes